Further study on the role of SLAMF9 and GRK3 in the microenvironment and tumor progression of laryngeal chondrosarcoma may provide clues for laryngeal chondrosarcoma pathogenesis and potential new therapeutic targets. The gene discussed is GRK3; the disease is neoplasm.